相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer
Dong Hoon Suh et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Metformin intake is associated with better survival in ovarian cancer A Case-Control Study
Sanjeev Kumar et al.
CANCER (2013)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
Javier A. Menendez et al.
CELL CYCLE (2013)
The Effects of Metformin on Ovarian Cancer A Systematic Review
Piyemeth Dilokthornsakul et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Diabetes Mellitus and Ovarian Cancer Risk A Systematic Review and Meta-Analysis of Observational Studies
Jung-Yun Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
Mi Jeong Kwon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker et al.
MOLECULAR CANCER (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential
G. Yin et al.
ONCOGENE (2013)
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling
W. K. Chau et al.
ONCOGENE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells
Rafaela Erices et al.
REPRODUCTIVE SCIENCES (2013)
Role of the Microenvironment in Ovarian Cancer Stem Cell Maintenance
Jennifer Pasquier et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
Qinglei Zhan et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
Dongming Liang et al.
BMC CANCER (2012)
Ovarian cancer stem cell markers: Prognostic and therapeutic implications
Daniela Burgos-Ojeda et al.
CANCER LETTERS (2012)
Metformin and Cancer Stem Cells: Old Drug, New Targets
Filip Bednar et al.
CANCER PREVENTION RESEARCH (2012)
Cancer stem cells: In the line of fire
Malcolm R. Alison et al.
CANCER TREATMENT REVIEWS (2012)
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2012)
The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming
Athanasia D. Panopoulos et al.
CELL RESEARCH (2012)
Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal
Jin Zhang et al.
CELL STEM CELL (2012)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
Ruby Yun-Ju Huang et al.
CURRENT DRUG TARGETS (2012)
Inflammation and ovarian cancer
Antonio Maccio et al.
CYTOKINE (2012)
Five-year trends in mortality indices among gynecological cancer patients in Canada
Noori Akhtar-Danesh et al.
GYNECOLOGIC ONCOLOGY (2012)
Metformin targets ovarian cancer stem cells in vitro and in vivo
Jessica J. Shank et al.
GYNECOLOGIC ONCOLOGY (2012)
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
L. Cao et al.
ONCOGENE (2012)
Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway
Hong Liao et al.
ONCOLOGY REPORTS (2012)
Metformin inhibits the development and metastasis of ovarian cancer
Buchu Wu et al.
ONCOLOGY REPORTS (2012)
Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
Ardian Latifi et al.
PLOS ONE (2012)
Intratumoral Heterogeneity in the Self-Renewal and Tumorigenic Differentiation of Ovarian Cancer
Sagi Abelson et al.
STEM CELLS (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures
Daniel K. Chan et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
Ramandeep Rattan et al.
JOURNAL OF ONCOLOGY (2012)
Energy metabolism in nuclear reprogramming
Clifford D. L. Folmes et al.
BIOMARKERS IN MEDICINE (2011)
Ovarian cancer stem cells and inflammation
Gil Mor et al.
CANCER BIOLOGY & THERAPY (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Ketones and lactate increase cancer cell stemness, driving recurrence, metastasis and poor clinical outcome in breast cancer
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2011)
Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
Clifford D. L. Folmes et al.
CELL METABOLISM (2011)
UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells
Jin Zhang et al.
EMBO JOURNAL (2011)
Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer
Jae Hong No et al.
GYNECOLOGIC ONCOLOGY (2011)
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
Amber Yasmeen et al.
GYNECOLOGIC ONCOLOGY (2011)
Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells
Anna Priebe et al.
GYNECOLOGIC ONCOLOGY (2011)
The impact of diabetes on survival in women with ovarian cancer
Arvind Bakhru et al.
GYNECOLOGIC ONCOLOGY (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Cisplatin Treatment of Primary and Metastatic Epithelial Ovarian Carcinomas Generates Residual Cells With Mesenchymal Stem Cell-Like Profile
Ardian Latifi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
Sandro Pignata et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
Jae-Ho Cheong et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Sian Rizzo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
C. Algire et al.
ONCOGENE (2011)
Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: Correlation of protein expression and GC/TOF-MS-based metabolomics
Ann-Christin Buckendahl et al.
ONCOLOGY REPORTS (2011)
Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
Robert Strauss et al.
PLOS ONE (2011)
Human Induced Pluripotent Stem Cells Harbor Homoplasmic and Heteroplasmic Mitochondrial DNA Mutations While Maintaining Human Embryonic Stem Cell-like Metabolic Reprogramming
Alessandro Prigione et al.
STEM CELLS (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Ruihuan Chen et al.
CANCER CELL (2010)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
N. Ahmed et al.
CURRENT CANCER DRUG TARGETS (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
CD133 antigen expression in ovarian cancer
Gabriella Ferrandina et al.
BMC CANCER (2009)
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Vuk Stambolic et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
Metformin inhibits TNF-α-induced IκB kinase phosphorylation, IκB-α degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation
Nan-Lan Huang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
Nawneet K. Kurrey et al.
STEM CELLS (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
The effect of metformin treatment on VEGF and PAI-1 Levels in obese type 2 diabetic patients
Canan Ersoy et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes
Soren S. Lund et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
R. Chen et al.
ONCOGENE (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
MG Kelly et al.
CANCER RESEARCH (2006)
Ovarian cancer is a heterogeneous disease
V Wang et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
分享论文
